Get started
RocketTickers

Myovant Sciences Announces Positive Results from Second Phase 3

Long
RocketTickers  
NYSE:MYOV   None
Beyond Technical Analysis
5
0
beyondta
MYOV: Myovant Sciences, Inc.
2020-06-23 07:30:10
Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.